RANIVISIO sol inj 2.3 mg/0.23ml flac 0.23 ml
7680690680015
CH-69068
S01LA04
11.99.0.
Reimbursement limitations:
RANIVISIO
Pour le traitement de la dégénérescence maculaire liée à l’âge exsudative (humide) – DMLA, d’une …
1 / 3
google
Details
- Product number
- 6906801
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ranibizumabum 10 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Ranivisio 10 mg/mL, Injektionslösung in Durchstechflasche
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 620.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2024
Authorization holder
Bioeq AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69068
- Drug name
- Ranivisio, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- S01LA04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/08/2023
- Authorization expiration date
- 03/08/2028
- IT number
- 11.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RANIVISIO sol inj 2.3 mg/0.23ml flac 0.23 ml
- Description (DE)
- RANIVISIO Inj Lös 2.3 mg/0.23ml Durchstf 0.23 ml
- Market launch
- 04/08/2023
- Narcotic (BTM)
- No